0002035989-26-000017
SEC filingAmrize Ltd (AMRZ) reported strong financial performance for fiscal year 2025, with revenues of $11.81 billion and net income attributable to the Company of $1.19 billion. The company generated a gross profit of $3.03 billion, representing a gross margin of 25.7%, and operating income of $1.91 billion, resulting in an operating margin of 16.2%. Earnings per share were $2.00 for both basic and diluted calculations. The balance sheet shows total assets of $24.25 billion, with significant goodwill of $9.02 billion and property, plant and equipment of $7.93 billion. The company maintained a solid liquidity position with $1.92 billion in cash and cash equivalents. Cash flow from operations was robust at $2.21 billion, though the company used $361 million in investing activities and $1.55 billion in financing activities. The financial results demonstrate the company's ability to generate substantial profits and cash flow while maintaining a strong asset base.
Amrize Ltd delivered strong financial results for fiscal year 2025, reporting revenues of $11.81 billion and net income attributable to the Company of $1.19 billion. The company achieved a gross profit of $3.03 billion, representing a gross margin of 25.7%. Operating income was $1.91 billion, resulting in an operating margin of 16.2%. Earnings per share were $2.00 for both basic and diluted calculations. The company's cost structure included $8.78 billion in cost of revenues and $1.13 billion in selling, general and administrative expenses. Interest expense was significant at $413 million, while income tax expense totaled $326 million. The company also reported $11 million in income from equity method investments.
The company reported total revenues of $11.81 billion for fiscal year 2025. No segment breakdown or geographic mix was provided in the available data. The revenue figure represents the company's total sales for the period, with cost of revenues totaling $8.78 billion. The document does not disclose specific revenue drivers, product categories, or customer segments that contributed to the revenue performance. Without additional segment data, the analysis is limited to the consolidated revenue figure.
Amrize Ltd maintained healthy profitability margins in fiscal year 2025. The gross margin was 25.7%, calculated from gross profit of $3.03 billion on revenues of $11.81 billion. The operating margin was 16.2%, derived from operating income of $1.91 billion. The company's cost structure included significant selling, general and administrative expenses of $1.13 billion, which represented 9.6% of revenues. The net income margin was 10.1%, based on net income attributable to the Company of $1.19 billion. The company reported both a gain on disposal of long-lived assets and a loss on impairments, each totaling $15 million, which offset each other in the operating income calculation.
The company generated strong operating cash flow of $2.21 billion, significantly exceeding net income of $1.18 billion. Key adjustments included $914 million in depreciation, depletion, accretion and amortization. Free cash flow, calculated as operating cash flow minus capital expenditures of $788 million, was $1.85 billion. The balance sheet shows total assets of $24.25 billion, including $9.02 billion in goodwill, $7.93 billion in property, plant and equipment, and $1.73 billion in intangible assets. Current assets totaled $4.68 billion, with $1.92 billion in cash and cash equivalents. Total liabilities were $10.99 billion, including $4.94 billion in long-term debt and $1.54 billion in accounts payable. Equity attributable to the Company was $13.26 billion.
The filing does not provide specific management guidance, strategic priorities, or forward-looking statements in the available data. No information about future expectations, growth projections, or risk factors specific to the outlook is disclosed in the provided financial statements. The analysis is therefore limited to the historical financial results for fiscal year 2025 as presented in the income statement, balance sheet, and cash flow statement. Investors should refer to the complete 10-K filing for any management discussion and analysis sections that might contain forward-looking information.